Selames 15 mg spot-on solution for cats and dogs = 2.5 kg

Pays: Irlande

Langue: anglais

Source: HPRA (Health Products Regulatory Authority)

Ingrédients actifs:

Selamectin

Disponible depuis:

Krka, d.d., Novo mesto

Code ATC:

QP54AA05

DCI (Dénomination commune internationale):

Selamectin

Dosage:

15 mg/pipette

forme pharmaceutique:

Spot-on solution

Type d'ordonnance:

POM: Prescription Only Medicine as defined in relevant national legislation

Domaine thérapeutique:

selamectin

Statut de autorisation:

Authorised

Date de l'autorisation:

2018-12-21

Résumé des caractéristiques du produit

Health Products Regulatory Authority
20 April 2021
CRN00C74F
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Selames 15 mg spot-on solution for cats and dogs ≤ 2.5 kg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 0.25 ml pipette contains:
​
​
​
ACTIVE SUBSTANCE:
​
​
​
Selamectin
​15
​
mg
​
EXCIPIENTS:
​
​
​
Butylhydroxytoluene (E321)
​0.2
​
mg
​
For the full list of excipients, see section 6.1.
​
​
3 PHARMACEUTICAL FORM
Spot-on solution.
Clear, colourless to yellow to brown solution.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cats and dogs (≤ 2.5 kg)
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
CATS AND DOGS:

TREATMENT AND PREVENTION OF FLEA INFESTATIONS caused by
_Ctenocephalides _spp. for one month following a single
administration. This is as a result of the adulticidal, larvicidal and
ovicidal properties of the product. The product is
ovicidal for 3 weeks after administration. Through a reduction in the
flea population, monthly treatment of
pregnant and lactating animals will also aid in the prevention of flea
infestations in the litter up to seven weeks of
age. The product can be used as part of a treatment strategy for flea
allergy dermatitis and through its ovicidal and
larvicidal action may aid in the control of existing environmental
flea infestations in areas to which the animal has
access.

PREVENTION OF HEARTWORM DISEASEcaused by _Dirofilaria immitis _with
monthly administration.

TREATMENT OF EAR MITES (_Otodectes cynotis_).
CATS:

TREATMENT OF BITING LICE INFESTATIONS (_Felicola subrostratus_)

TREATMENT OF ADULT ROUNDWORMS (_Toxocara cati_)

TREATMENT OF ADULT INTESTINAL HOOKWORMS (_Ancylostoma tubaeforme_)
DOGS:

TREATMENT OF BITING LICE INFESTATIONS (_Trichodectes canis_)

TREATMENT OF SARCOPTIC MANGE (caused by _Sarcoptes scabiei_)

TREATMENT OF ADULT INTESTINAL ROUNDWORMS (_Toxocara canis_)
4.3 CONTRAINDICATIONS
Do not use in animals under 6 weeks of age.
Do not use in cats tha